Replies to post #10425 on Value Microcaps Zip Code Changers

[CPTMatt]

I thought this was good news although probably not surprising to people who are following the company closely. The mention of finding strategic partners I thought was good (although again, not surprising).

[Bobwins]

ATE.v/ATBPF +.04 to C$.50 4.4million shares traded

Antibe has been retracing for several weeks from the big spike on 3/20/18 when good phase II results were announced. Hit a high of C$.79 on that day but quickly fell into the high C$.30's. Lots of warrants were exercised and converted since the big day but I think we are mostly thru those shares.

I sold 1/2 in the C$.60's on the 20th but have bought those shares back in the low .40's. It could take a long time for the company to negotiate a deal with a big pharma to finance the phase III studies but I have decided to hold for the mid/long term.

An announcement of a deal should cause the stock to explode to new highs. Eventually when the drug is approved and commercialized, ATE.v could be in the C$4-5 range but that's likely in 2021 and beyond. So a long time away....